{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T09:53:16Z","timestamp":1774605196621,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>\n                    This study evaluates the efficacy and safety of levofloxacin (LVX) prophylaxis against bacteremia and febrile neutropenia in infants under 6 months of age compared with those 6 months to 2 years old with acute myeloid leukemia (AML), relapsed acute lymphoblastic leukemia (rALL), infant ALL (iALL), Down syndrome with ALL (DS ALL), or undergoing hematopoietic stem cell transplantation (HSCT). A retrospective chart review was conducted at Children\u2019s Mercy Hospital, Kansas City, MO (April 2019 to September 2024), including 79 encounters from patients receiving LVX prophylaxis. Data were collected on occurrences of bacteremia, febrile neutropenia, and adverse drug reactions. Bacteremia occurred in 9% of patient encounters with no significant difference between the infants under 6 months and the older age group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.643). Secondary outcomes of total duration of treatment antibiotic exposure and increases in liver enzymes were statistically different between groups. However, based on underlying differences in baseline characteristics, the results do not support definitive clinical significance. Other secondary outcomes, including febrile neutropenia, total LVX exposure, and time to first fever, showed no difference between groups. Of 7 positive blood cultures, susceptibility testing for LVX was performed for one culture isolate of\n                    <jats:italic toggle=\"yes\">Streptococcus mitis<\/jats:italic>\n                    , and it was resistant to LVX. This preliminary data indicates that further research is needed in this underexplored topic to confirm these findings with larger patient populations and explore long-term safety in this vulnerable population.\n                  <\/jats:p>","DOI":"10.1097\/mph.0000000000003184","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:10Z","timestamp":1773360010000},"page":"e118-e127","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic Levofloxacin Use in Oncology and Hematopoietic Stem Cell Transplants for Children Under 2 Years of Age"],"prefix":"10.1097","volume":"48","author":[{"given":"Ali","family":"Goldensoph","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Children\u2019s Mercy Hospital (CMH), Kansas City, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Mauro","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Children\u2019s Mercy Hospital (CMH), Kansas City, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Freudenthal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Children\u2019s Mercy Hospital (CMH), Kansas City, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaina N.","family":"Burns","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Children\u2019s Mercy Hospital (CMH), Kansas City, MO"},{"name":"University of Missouri School of Pharmacy, Kansas City, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R.","family":"Lee","sequence":"additional","affiliation":[{"name":"CMH Department of Health Services and Outcomes Research, Kansas City, MO"},{"name":"University of Missouri School of Medicine, Kansas City, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"R1-20260327","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/ciq147","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R2-20260327","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/asheducation.V2012.1.174.3798251","article-title":"How to approach neutropenia","volume":"2012","author":"Boxer","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"supplement_4","key":"R3-20260327","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jpids\/piae093.029","article-title":"Bacteremias in hemato-oncological pediatric patients: clinical and microbiological characteristics","volume":"13","author":"Viridiana","year":"2024","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R4-20260327","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cncr.21134","article-title":"Typhlitis in childhood cancer","volume":"104","author":"McCarville","year":"2005","journal-title":"Cancer"},{"key":"R5-20260327","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1097\/INF.0000000000003556","article-title":"Diagnosis and management of typhlitis and neutropenic enterocolitis in children with cancer","volume":"41","author":"Cross","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20260327","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cid\/ciz1082","article-title":"Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation","volume":"71","author":"Lehrnbecher","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R7-20260327","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1097\/MPH.0000000000001814","article-title":"Pediatric febrile neutropenia: change in etiology of bacteremia, empiric choice of therapy and clinical outcomes","volume":"42","author":"Alali","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"R9-20260327","doi-asserted-by":"crossref","first-page":"e29525","DOI":"10.1002\/pbc.29525","article-title":"Levofloxacin prophylaxis for pediatric leukemia patients: longitudinal follow-up for impact on health care-associated infections","volume":"69","author":"Davis","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"R10-20260327","doi-asserted-by":"crossref","first-page":"e31059","DOI":"10.1002\/pbc.31059","article-title":"The impact of levofloxacin prophylaxis on empiric intravenous antibiotic use in pediatric hematopoietic stem cell transplant recipients","volume":"71","author":"Prodanuk","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20260327","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/cid\/cix644","article-title":"Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia","volume":"65","author":"Wolf","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R12-20260327","doi-asserted-by":"crossref","first-page":"e26952","DOI":"10.1002\/pbc.26952","article-title":"Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia","volume":"65","author":"Sulis","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R13-20260327","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA"},{"key":"R14-20260327","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/antibiotics10121523","article-title":"Levofloxacin versus ciprofloxacin-based prophylaxis during the pre-engraftment phase in allogeneic hematopoietic stem cell transplant pediatric recipients: a single-center retrospective matched analysis","volume":"10","author":"Servidio","year":"2021","journal-title":"Antibiotics"},{"key":"R15-20260327","doi-asserted-by":"crossref","first-page":"167.e1","DOI":"10.1016\/j.jtct.2021.11.017","article-title":"Safety and efficacy of prophylactic levofloxacin in pediatric and adult hematopoietic stem cell transplantation patients","volume":"28","author":"Gardner","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"R16-20260327","first-page":"185","article-title":"Effects of levofloxacin prophylaxis in pediatric patients with acute myeloid leukemia, relapsed acute lymphoblastic leukemia, or patients undergoing hematopoietic stem cell transplant","volume":"13","author":"Linden","year":"2023","journal-title":"J Hematol Oncol Pharm"},{"issue":"e90","key":"R17-20260327","first-page":"1","article-title":"Levofloxacin prophylaxis for pediatric leukemia patients: monitoring of outcomes for sustained benefit and consequences","volume":"4","author":"Davis","year":"2024","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"R18-20260327","first-page":"FC21","article-title":"Antibiotic prescribing pattern in a tertiary level neonatal intensive care unit","volume":"9","author":"Suryawanshi","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"R19-20260327","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7206a1","article-title":"CDC guidelines for the prevention and treatment of anthrax, 2023","volume":"72","author":"Bower","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"R20-20260327","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jhin.2016.07.008","article-title":"An unusual source of Burkholderia cepacia outbreak in a neonatal intensive care unit","volume":"94","author":"Shrivastava","year":"2016","journal-title":"J Hosp Infect"},{"key":"R21-20260327","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3390\/pathogens10081031","article-title":"Severe pneumonia in neonates associated with Legionella pneumophila: case report and review of the literature","volume":"10","author":"Perez Ortiz","year":"2021","journal-title":"Pathogens"},{"key":"R22-20260327","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.2147\/IDR.S541464","article-title":"The first reported case of infant soft tissues infection cause by Legionella maceachernii: a case report and literature review","volume":"18","author":"Zhang","year":"2025","journal-title":"Infect Drug Resist"},{"key":"R23-20260327","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1111\/ped.15814","article-title":"Mycoplasma hominis meningitis in a neonate successfully treated with levofloxacin","volume":"66","author":"Kuroda","year":"2024","journal-title":"Pediatr Int"},{"key":"R24-20260327","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/crpm-2013-0063","article-title":"Refractory shock secondary to treatment with levofloxacin in an extremely low birth weight infant affected by Stenotrophomonas maltophilia pneumonia","volume":"4","author":"Leante-Castellanos","year":"2015","journal-title":"Case Rep Perinat Med"},{"key":"R25-20260327","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1080\/14767058.2021.1904876","article-title":"A dangerous causative microorganism of early onset neonatal sepsis: Stenotrophomonas maltophilia. Two case reports and a review of the literature","volume":"35","author":"Mutlu","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R26-20260327","doi-asserted-by":"crossref","first-page":"S268","DOI":"10.1016\/j.mjafi.2023.01.010","article-title":"Stenotrophomonas maltophilia sepsis in preterm neonates","volume":"80","author":"Verma","year":"2024","journal-title":"Armed Forces Med J India"},{"key":"R27-20260327","first-page":"64","article-title":"High direct bilirubin associated with levofloxacin use in a neonate","volume":"25","author":"Holmes","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R28-20260327","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/cid\/ciae024","article-title":"Pharmacokinetics and optimal dosing of levofloxacin in children for drug-resistant tuberculosis: an individual patient data meta-analysis","volume":"78","author":"White","year":"2024","journal-title":"Clin Infect Dis"},{"key":"R29-20260327","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7003a1","article-title":"Antimicrobial treatment and prophylaxis of plague: recommendations for naturally acquired infections and bioterrorism response","volume":"70","author":"Nelson","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"R30-20260327","doi-asserted-by":"crossref","first-page":"e31532","DOI":"10.1002\/pbc.31532","article-title":"Prevention and management of infectious complications in pediatric patients with cancer: a survey assessment of current practices across children\u2019s oncology group institutions","volume":"72","author":"Slatnick","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"R32-20260327","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/antibiotics12101538","article-title":"Antimicrobial susceptibility to 27 drugs and the molecular mechanisms of macrolide, tetracycline, and quinolone resistance in Gemella sp","volume":"12","author":"Furugaito","year":"2023","journal-title":"Antibiotics"},{"key":"R33-20260327","first-page":"1","article-title":"Brevibacterium bacteremia in the setting of pyogenic liver abscess","volume":"1","author":"Hossain","year":"2021","journal-title":"Case Rep Infect Dis"},{"key":"R34-20260327","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/08880018.2024.2353888","article-title":"Levofloxacin prophylaxis in pediatric oncology and hematopoietic stem cell transplantation: a literature review","volume":"41","author":"Koo","year":"2024","journal-title":"Pediatr Hematol Oncol"},{"key":"R35-20260327","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/jpids\/piae077","article-title":"Fluoroquinolone prophylaxis in children with cancer: a pro\/con discussion","volume":"13","author":"Vasileiadi","year":"2024","journal-title":"JPIDS"},{"key":"R36-20260327","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1002\/cam4.3249","article-title":"Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia","volume":"9","author":"Karol","year":"2020","journal-title":"Cancer Med"},{"key":"R37-20260327","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40746-022-00251-0","article-title":"Review: Levofloxacin prophylaxis in pediatric oncology patients","volume":"8","author":"Scheuermann","year":"2022","journal-title":"Curr Treat Options Pediatr"},{"key":"R38-20260327","doi-asserted-by":"crossref","first-page":"e2023062307","DOI":"10.1542\/peds.2023-062307","article-title":"Clostridioides difficile infection in children: recent updates on epidemiology, diagnosis, therapy","volume":"152","author":"Shirley","year":"2023","journal-title":"Pediatrics"},{"key":"R39-20260327","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/S2666-5247(20)30202-0","article-title":"Antibiotic prophylaxis and the gastrointestinal resistome in paediatric patients with acute lymphoblastic leukaemia: a cohort study with metagenomic sequencing analysis","volume":"2","author":"Margolis","year":"2021","journal-title":"Lancet Microbe"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T09:00:15Z","timestamp":1774602015000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003184","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"2025-07-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}